Amsterdam Cardiovascular Sciences

Sodium-glucose co-transporters (SGLT2) inhibitors prevent lipid droplets formation in vascular inflammation or lipid overload by SGLT2-independent mechanism

Chorazy, N., Wojnar-Lason, K., Gdula, A. M., Bakker, D., Zuurbier, C. J., Chlopicki, S. & Pacia, M. Z., 1 Apr 2025, In: Biomedicine and Pharmacotherapy. 185, 117967.

Research output: Contribution to journal › Article* › Academic › peer-review

The innate immune receptor NLRX1 is a novel required modulator for mPTP opening: implications for cardioprotection

Xiao, Y., Hu, X., Rudolphi, C. F., Nollet, E. E., Nederlof, R., Wang, Q., Bakker, D., Nikolaou, P. E., Knol, J. C., Haas, R. R.G.-D., Henneman, A. A., Pham, T. V., Jimenez, C. R., Grootemaat, A. E., van der Wel, N. N., Girardin, S. E., Kaludercic, N., van der Velden, J., Onódi, Z. & Leszek, P. & 7 others, Varga, Z. V., Ferdinandy, P., Preckel, B., Weber, N. C., Hollmann, M. W., di Lisa, F. & Zuurbier, C. J., 2025, (E-pub ahead of print) In: Basic Res. Cardiol..

Research output: Contribution to journal › Article* › Academic › peer-review

Empagliflozin prevents heart failure through inhibition of the NHE1-NO pathway, independent of SGLT2

Chen, S., Wang, Q., Bakker, D., Hu, X., Zhang, L., van der Made, I., Tebbens, A. M., Kovácsházi, C., Giricz, Z., Brenner, G. B. B., Ferdinandy, P., Schaart, G., Gemmink, A., Hesselink, M. K. C., Rivaud, M. R., Pieper, M. P., Hollmann, M. W., Weber, N. C., Balligand, J.-L. & Creemers, E. E. & 2 others, Coronel, R. & Zuurbier, C. J., Oct 2024, In: Basic research in cardiology. 119, 5, p. 751-772 22 p.

Research output: Contribution to journal › Article* › Academic › peer-review